Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06768749 · ClinicalTrials.gov registry record · NA
The Impact of Melatonin Lotion on Sleep and Mental Health
A NA study of Sleep Problems and Depressive Disorder and Anxiety Disorders, sponsored by University of Redlands.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06768749: Recruiting NA study of Sleep Problems and Depressive Disorder and Anxiety Disorders, sponsored by University of Redlands.
NCT06768749 is a NA study of Sleep Problems and Depressive Disorder and Anxiety Disorders that is actively recruiting participants, run by University of Redlands. The registered enrollment target is 60 participants, roughly in line with the 62-participant average among 7 other Sleep Problems trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06768749, a NA study of Sleep Problems and Depressive Disorder and Anxiety Disorders, is actively recruiting participants, sponsored by University of Redlands.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the effect that melatonin lotion has on sleep quality, the nervous system, and mental health. Melatonin is a hormone secreted by the brain that regulates sleep and might improve depression and anxiety symptoms. The goal is to determine whether melatonin in lotion form is an effective treatment for young adults with inadequate sleep and might improve mental health. Participants will fill out surveys, wear an actigraph (a wrist-worn device that measures sleep), wear a heart rate monitor (a strap worn around one's chest), and provide nightly saliva samples during treatment weeks. In one of the two treatment weeks, participants will receive a lotion that contains melatonin. During the other week they will receive a control treatment that will be lotion with no melatonin, and there will be a week in between with no treatment at all.
Primary Outcome
PROMIS SF v1.0 - Sleep Disturb 8b
Conditions Studied
Interventions
- OTHER Melatonin lotion
- OTHER Placebo lotion
Study Locations (1)
California
- University of Redlands - Redlands
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-02-28 |
| Est. Completion | 2028-04-01 |
| Phase | NA |
What NCT06768749 shows while recruiting
NCT06768749 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, roughly in line with the 62-participant average among 7 other Sleep Problems trials with a reported enrollment target.
The record links to 2 conditions, with Sleep Problems appearing as the primary indexed condition, and to 2 interventions - of which Melatonin lotion is the first listed.
NCT06768749 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06768749 about?
NCT06768749 is a clinical study titled "The Impact of Melatonin Lotion on Sleep and Mental Health". The purpose of this study is to examine the effect that melatonin lotion has on sleep quality, the nervous system, and mental health. Melatonin is a hormone secreted by the brain that regulates sleep and might improve depression and anxiety symptoms. The goal is to determine whether melatonin in lot...
What is the current status of trial NCT06768749?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-02-28. Estimated completion is 2028-04-01.
What conditions does trial NCT06768749 study?
This clinical trial studies the following conditions: Sleep Problems, Depressive Disorder and Anxiety Disorders.
What interventions are being tested in trial NCT06768749?
The interventions under investigation include: Melatonin lotion (OTHER), Placebo lotion (OTHER).
Who is sponsoring clinical trial NCT06768749?
This trial is sponsored by University of Redlands, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06768749 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Problems
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sleep Treatment for Teens (RCT Phase)
RECRUITING · NA
-
A Non-Pharmacological Method for Enhancing Sleep in PTSD
COMPLETED · NA
-
Evaluation Study of Talk Parenting Skills
COMPLETED · NA
-
Tart Cherry Juice for Sleep in Older Adults With Insomnia: A Pilot Study of Feasibility and Comprehensive Mechanisms
COMPLETED · NA
-
Use of CBD in the Treatment of Anxiety
RECRUITING · Phase 2
-
Good Nights Sleep Program to Improve Child and Family Sleep
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI